E-LIB Suche - Ergebnisse für: Pluzanski, Adam

1

Clinicopathological characteristics of patients with primar..:

Piórek, Aleksandra ; Płużański, Adam ; Teterycz, Paweł...
Thoracic Cancer. 15 (2024) 11 - p. 878-883 , 2024

Link: https://doi.org/10.1111/..

2

Treatment outcomes of patients with primary tracheal tumors..:

Piórek, Aleksandra ; Płużański, Adam ; Knetki-Wróblewska, Magdalena...
BMC Cancer. 24 (2024) 1 - p. , 2024

Link: https://doi.org/10.1186/..

3

Treatment Patterns, Testing Practices, and Outcomes in Pati..:

Pluzanski, Adam ; Bryl, Maciej ; Chmielewska, Izabela...
Cancers. 15 (2023) 5 - p. 1581 , 2023

Link: https://doi.org/10.3390/..

4

Nivolumab or Atezolizumab in the Second-Line Treatment of A..:

Knetki-Wróblewska, Magdalena ; Tabor, Sylwia ; Piórek, Aleksandra...
Journal of Clinical Medicine. 12 (2023) 6 - p. 2409 , 2023

Link: https://doi.org/10.3390/..

5

Safety of First-Line Nivolumab Plus Ipilimumab in Patients ..:

Paz-Ares, Luis G. ; Ciuleanu, Tudor-Eliade ; Pluzanski, Adam...
Journal of Thoracic Oncology. 18 (2023) 1 - p. 79-92 , 2023

Link: https://doi.org/10.1016/..

6

Real-World Experience in Treatment of Patients with Non-Sma..:

Janzic, Urska ; Shalata, Walid ; Szymczak, Katarzyna...
International Journal of Molecular Sciences. 24 (2023) 16 - p. 12840 , 2023

Link: https://doi.org/10.3390/..

7

Beta Blockers with Statins May Decrease All-Cause Mortality..:

Zaborowska-Szmit, Magdalena ; Szmit, Sebastian ; Olszyna-Serementa, Marta...
Cancers. 15 (2023) 4 - p. 1277 , 2023

Link: https://doi.org/10.3390/..

8

Systemic and Intracranial Outcomes With First-Line Nivoluma..:

Reck, Martin ; Ciuleanu, Tudor-Eliade ; Lee, Jong-Seok...
Journal of Thoracic Oncology. 18 (2023) 8 - p. 1055-1069 , 2023

Link: https://doi.org/10.1016/..

9

Efficacy of Immunotherapy in Second-Line Treatment of KRAS-..:

Knetki-Wróblewska, Magdalena ; Tabor, Sylwia ; Płużański, Adam...
Current Oncology. 30 (2022) 1 - p. 462-475 , 2022

Link: https://doi.org/10.3390/..

10

Assessing the impact of antiemetic guideline compliance on ..:

Aapro, Matti ; Caprariu, Zoe ; Chilingirov, Petio...
European Journal of Cancer. 166 (2022) - p. 126-133 , 2022

Link: https://doi.org/10.1016/..

11

First-Line Nivolumab Plus Ipilimumab in Advanced NSCLC: 4-Y..:

Paz-Ares, Luis G. ; Ramalingam, Suresh S. ; Ciuleanu, Tudor-Eliade...
Journal of Thoracic Oncology. 17 (2022) 2 - p. 289-308 , 2022

Link: https://doi.org/10.1016/..

12

Real-World Testing Practices, Treatment Patterns and Clinic..:

Janžič, Urška ; Turnšek, Nina ; Dediu, Mircea...
Current Oncology. 29 (2022) 8 - p. 5833-5845 , 2022

Link: https://doi.org/10.3390/..

13

RET Proto-Oncogene—Not Such an Obvious Starting Point in Ca..:

Kucharczyk, Tomasz ; Krawczyk, Paweł ; Kowalski, Dariusz M....
Cancers. 14 (2022) 21 - p. 5298 , 2022

Link: https://doi.org/10.3390/..

14

Real-World Journey of Unresectable Stage III NSCLC Patients..:

Agbarya, Abed ; Shalata, Walid ; Addeo, Alfredo...
Journal of Clinical Medicine. 11 (2022) 6 - p. 1738 , 2022

Link: https://doi.org/10.3390/..

15

Do We Need TNM for Tracheal Cancers? Analysis of a Large Re..:

Piórek, Aleksandra ; Płużański, Adam ; Teterycz, Paweł..
Cancers. 14 (2022) 7 - p. 1665 , 2022

Link: https://doi.org/10.3390/..